|
Submission EDG-MED-4c68219f
|
|
0
|
98
|
November 30, 2020
|
|
Submission DAR-DIA-076fb6ea
|
|
6
|
215
|
November 30, 2020
|
|
Submission ED_-GRI-5b13fbe2
|
|
1
|
339
|
November 30, 2020
|
|
Submission DAR-DIA-56cf811e
|
|
0
|
100
|
November 30, 2020
|
|
Submission ALP-POS-e980f4ea
|
|
0
|
103
|
November 28, 2020
|
|
Submission ALP-POS-75715966
|
|
1
|
377
|
November 27, 2020
|
|
Non-covalent Ugi crystal structures?
|
|
2
|
448
|
November 27, 2020
|
|
Submission MIC-UNK-08fa0751
|
|
0
|
108
|
November 26, 2020
|
|
Submission ALP-POS-fab80cf2
|
|
0
|
117
|
November 25, 2020
|
|
Submission TER-UNK-b9d4d16f
|
|
0
|
112
|
November 25, 2020
|
|
Submission LAU-MED-88a3970a
|
|
0
|
108
|
November 25, 2020
|
|
Submission JUR-SOU-0920801e
|
|
0
|
113
|
November 25, 2020
|
|
Filter out covalent ligands
|
|
9
|
715
|
November 24, 2020
|
|
Submission DAR-DIA-5ff57136
|
|
20
|
1076
|
November 24, 2020
|
|
Submission PET-UNK-12d8d43f
|
|
0
|
112
|
November 23, 2020
|
|
Submission PET-UNK-6c2be958
|
|
0
|
123
|
November 22, 2020
|
|
Submission PET-UNK-752bebd6
|
|
5
|
200
|
November 22, 2020
|
|
Development/clinical chemistry
|
|
1
|
469
|
November 21, 2020
|
|
Submission JOH-UNI-a38a7bdd
|
|
0
|
122
|
November 19, 2020
|
|
Submission BEN-DND-a7517465
|
|
0
|
121
|
November 19, 2020
|
|
Submission EDG-MED-971238d3
|
|
0
|
128
|
November 19, 2020
|
|
Submission PET-UNK-82544c07
|
|
1
|
164
|
November 19, 2020
|
|
Submission ALP-POS-ce760d3f
|
|
0
|
130
|
November 18, 2020
|
|
Submission DAR-DIA-9e4459de
|
|
0
|
120
|
November 18, 2020
|
|
Submission VLA-UCB-29506327
|
|
0
|
121
|
November 17, 2020
|
|
Submission MAT-POS-8fd29122
|
|
0
|
110
|
November 17, 2020
|
|
Submission MAT-POS-23a8a11a
|
|
0
|
111
|
November 17, 2020
|
|
Submission MAT-POS-450cb4f9
|
|
0
|
120
|
November 17, 2020
|
|
Merging 3-aminopyridine and quinolone series using dihydrouracil linker
|
|
2
|
587
|
November 16, 2020
|
|
Submission NYW-FNM-5d3bc4bf
|
|
0
|
154
|
November 15, 2020
|